Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 16;13(10):e073459.
doi: 10.1136/bmjopen-2023-073459.

Feasibility and impact of online HIV/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial

Cristina Agustí  1   2   3 , Héctor Martínez Riveros  4   3   5 , Jorge García-Pérez  6 , Vicente Descalzo  6 , Gema Fernandez  7 , Aida Ramírez-Marinero  7 , Maria Victoria Gonzalez  4   2   7 , Yesika Díaz  4   2 , Marcos Montoro-Fernandez  4 , Pol Romano-deGea  4   3 , Silvia G Araujo  4 , Esteve Muntada  4   3 , Jordi Casabona  4   2   3   8
Affiliations

Feasibility and impact of online HIV/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial

Cristina Agustí et al. BMJ Open. .

Abstract

Introduction: The objectives of the study are: to design and implement a pilot intervention to offer self-sampling kits to detect HIV, Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Treponema pallidum (TP) among gay, bisexual and other men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) as part of PrEP follow-up. To evaluate if the pilot intervention causes a reduction of the retention to PrEP follow-up among the target population. To analyse the capacity of the intervention to reduce the healthcare burden on the PrEP service. To evaluate the acceptability of the intervention among PrEP users and PrEP service healthcare workers and; to validate dried blood samples for treponemal and non-treponemal antibody detection using the Dual Path Platform syphilis screening and confirmatory assay compared with blood drawn by venous puncture.

Methods and analysis: We will perform a non-blinded randomised controlled non-inferiority trial among PrEP users on follow-up. Participants on the control arm will follow the usual follow-up protocol with quarterly face-to-face visits where they will be tested for HIV and sexually transmitted infections (STIs). Participants in the experimental arm will alternate face-to-face meetings with online screening of HIV and STIs. The website https://testate.org/ will include a module for online follow-up visits of participants. Participants of the experimental arm will order self-sampling kits for HIV, CT, NG and TP through the website, will send the samples to the laboratory and check their results online. We will compare the retention to follow up and the healthcare burden in both arms. The acceptability of the intervention among participants and healthcare workers will be assessed.

Ethics and dissemination: The project has been approved by the CEIC-HUGTIP (Reference: PI-22-051). Subjects will be included after giving their informed consent. Final conclusions and recommendations will be shared with stakeholders. Two publications in peer-reviewed journals are expected.

Trial registration number: NCT05752643.

Keywords: HIV & AIDS; clinical trial; sexually transmitted disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow diagram of study enrolment, randomisation, intervention arms, follow-up and analysis. CT, Chlamydia trachomatis; GBMSM, gay, bisexual and other men who have sex with men; NG, Neisseria gonorrhoeae; PrEP, pre-exposure prophylaxis; STI, sexually transmitted infection; TP, Treponema pallidum.
See this image and copyright information in PMC

References

    1. Centro Nacional de Epidemiología . Vigilancia Epidemiológica del VIH Y SIDA en España 2021 Sist INF Sobre Nuevos Diagnósticos VIH Regist Nac Casos SIDA plan Nac Sobre El SIDA. 2022. Available: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/...
    1. McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2016;387:53–60. 10.1016/S0140-6736(15)00056-2 - DOI - PMC - PubMed
    1. Grant RM, Lama JR, Anderson PL, et al. Preexposure Chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587–99. 10.1056/NEJMoa1011205 - DOI - PMC - PubMed
    1. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in Heterosexual men and women. N Engl J Med 2012;367:399–410. 10.1056/NEJMoa1108524 - DOI - PMC - PubMed
    1. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral Preexposure prophylaxis for Heterosexual HIV transmission in Botswana. N Engl J Med 2012;367:423–34. 10.1056/NEJMoa1110711 - DOI - PubMed

Publication types

Associated data